SKI Market

A+| A| A-|

Indian Indices

Sensex

75,237.99 -160.73
( -0.21%)

Global Indices

Nasdaq

49,543.85 -540.61
(-1.08%)

Dow Jones

7,428.26 -93.98
(-1.25%)

Hang Seng

61,141.50 -1,512.55
(-2.41%)

Nikkei 225

10,172.40 -200.53
(-1.93%)

Forex

USD-INR

95.64 0.03
(0.04%)

EUR-INR

112.06 -0.23
(-0.21%)

GBP-INR

129.33 -0.17
(-0.13%)

JPY-INR

0.61 0.00
(-0.10%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Everest Organics Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

524790

INE334C01029

74.6694113

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

43.05

250.82

EPS(TTM)

Face Value()

Div & Yield %

Back

Anuh Pharma standalone net profit rises 30.08% in the December 2025 quarter

Feb 07,2026

Net profit of Anuh Pharma rose 30.08% to Rs 13.45 crore in the quarter ended December 2025 as against Rs 10.34 crore during the previous quarter ended December 2024. Sales rose 23.62% to Rs 197.18 crore in the quarter ended December 2025 as against Rs 159.51 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	197.18	159.51	24
OPM %	8.52	9.27	-
PBDT	20.82	15.44	35
PBT	17.82	13.26	34
NP	13.45	10.34	30

75,237.99 -160.73 ( -0.21%)

49,543.85 -540.61 (-1.08%)

7,428.26 -93.98 (-1.25%)

61,141.50 -1,512.55 (-2.41%)

10,172.40 -200.53 (-1.93%)

95.64 0.03 (0.04%)

112.06 -0.23 (-0.21%)

129.33 -0.17 (-0.13%)

0.61 0.00 (-0.10%)